Copyright Reports & Markets. All rights reserved.

Global Chick Embryo Cell Rabies Vaccine Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Chick Embryo Cell Rabies Vaccine Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Post-Exposure Prophylaxis Vaccine
    • 1.3.3 Pre-Exposure Prophylaxis Vaccine
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Chick Embryo Cell Rabies Vaccine Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Clinic
    • 1.4.3 Hospital
    • 1.4.4 Pharmacy
    • 1.4.5 Others
  • 1.5 Global Chick Embryo Cell Rabies Vaccine Market Size & Forecast
    • 1.5.1 Global Chick Embryo Cell Rabies Vaccine Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Chick Embryo Cell Rabies Vaccine Sales Quantity (2020-2031)
    • 1.5.3 Global Chick Embryo Cell Rabies Vaccine Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 GlaxoSmithKline
    • 2.1.1 GlaxoSmithKline Details
    • 2.1.2 GlaxoSmithKline Major Business
    • 2.1.3 GlaxoSmithKline Chick Embryo Cell Rabies Vaccine Product and Services
    • 2.1.4 GlaxoSmithKline Chick Embryo Cell Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 GlaxoSmithKline Recent Developments/Updates
  • 2.2 Baxter International
    • 2.2.1 Baxter International Details
    • 2.2.2 Baxter International Major Business
    • 2.2.3 Baxter International Chick Embryo Cell Rabies Vaccine Product and Services
    • 2.2.4 Baxter International Chick Embryo Cell Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Baxter International Recent Developments/Updates
  • 2.3 Merck & Co., Inc.
    • 2.3.1 Merck & Co., Inc. Details
    • 2.3.2 Merck & Co., Inc. Major Business
    • 2.3.3 Merck & Co., Inc. Chick Embryo Cell Rabies Vaccine Product and Services
    • 2.3.4 Merck & Co., Inc. Chick Embryo Cell Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Merck & Co., Inc. Recent Developments/Updates
  • 2.4 Haffkine Bio-Pharmaceutical Corporation
    • 2.4.1 Haffkine Bio-Pharmaceutical Corporation Details
    • 2.4.2 Haffkine Bio-Pharmaceutical Corporation Major Business
    • 2.4.3 Haffkine Bio-Pharmaceutical Corporation Chick Embryo Cell Rabies Vaccine Product and Services
    • 2.4.4 Haffkine Bio-Pharmaceutical Corporation Chick Embryo Cell Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Haffkine Bio-Pharmaceutical Corporation Recent Developments/Updates
  • 2.5 Sanofi Pasteur
    • 2.5.1 Sanofi Pasteur Details
    • 2.5.2 Sanofi Pasteur Major Business
    • 2.5.3 Sanofi Pasteur Chick Embryo Cell Rabies Vaccine Product and Services
    • 2.5.4 Sanofi Pasteur Chick Embryo Cell Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Sanofi Pasteur Recent Developments/Updates
  • 2.6 Biological E. Limited
    • 2.6.1 Biological E. Limited Details
    • 2.6.2 Biological E. Limited Major Business
    • 2.6.3 Biological E. Limited Chick Embryo Cell Rabies Vaccine Product and Services
    • 2.6.4 Biological E. Limited Chick Embryo Cell Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Biological E. Limited Recent Developments/Updates
  • 2.7 Indian Immunologicals Ltd.
    • 2.7.1 Indian Immunologicals Ltd. Details
    • 2.7.2 Indian Immunologicals Ltd. Major Business
    • 2.7.3 Indian Immunologicals Ltd. Chick Embryo Cell Rabies Vaccine Product and Services
    • 2.7.4 Indian Immunologicals Ltd. Chick Embryo Cell Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Indian Immunologicals Ltd. Recent Developments/Updates
  • 2.8 Vaccine Research Center
    • 2.8.1 Vaccine Research Center Details
    • 2.8.2 Vaccine Research Center Major Business
    • 2.8.3 Vaccine Research Center Chick Embryo Cell Rabies Vaccine Product and Services
    • 2.8.4 Vaccine Research Center Chick Embryo Cell Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Vaccine Research Center Recent Developments/Updates
  • 2.9 Kaketsuken Co., Ltd.
    • 2.9.1 Kaketsuken Co., Ltd. Details
    • 2.9.2 Kaketsuken Co., Ltd. Major Business
    • 2.9.3 Kaketsuken Co., Ltd. Chick Embryo Cell Rabies Vaccine Product and Services
    • 2.9.4 Kaketsuken Co., Ltd. Chick Embryo Cell Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Kaketsuken Co., Ltd. Recent Developments/Updates
  • 2.10 Serum Institute of India
    • 2.10.1 Serum Institute of India Details
    • 2.10.2 Serum Institute of India Major Business
    • 2.10.3 Serum Institute of India Chick Embryo Cell Rabies Vaccine Product and Services
    • 2.10.4 Serum Institute of India Chick Embryo Cell Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Serum Institute of India Recent Developments/Updates
  • 2.11 RxList
    • 2.11.1 RxList Details
    • 2.11.2 RxList Major Business
    • 2.11.3 RxList Chick Embryo Cell Rabies Vaccine Product and Services
    • 2.11.4 RxList Chick Embryo Cell Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 RxList Recent Developments/Updates

3 Competitive Environment: Chick Embryo Cell Rabies Vaccine by Manufacturer

  • 3.1 Global Chick Embryo Cell Rabies Vaccine Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Chick Embryo Cell Rabies Vaccine Revenue by Manufacturer (2020-2025)
  • 3.3 Global Chick Embryo Cell Rabies Vaccine Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Chick Embryo Cell Rabies Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Chick Embryo Cell Rabies Vaccine Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Chick Embryo Cell Rabies Vaccine Manufacturer Market Share in 2024
  • 3.5 Chick Embryo Cell Rabies Vaccine Market: Overall Company Footprint Analysis
    • 3.5.1 Chick Embryo Cell Rabies Vaccine Market: Region Footprint
    • 3.5.2 Chick Embryo Cell Rabies Vaccine Market: Company Product Type Footprint
    • 3.5.3 Chick Embryo Cell Rabies Vaccine Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Chick Embryo Cell Rabies Vaccine Market Size by Region
    • 4.1.1 Global Chick Embryo Cell Rabies Vaccine Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Chick Embryo Cell Rabies Vaccine Consumption Value by Region (2020-2031)
    • 4.1.3 Global Chick Embryo Cell Rabies Vaccine Average Price by Region (2020-2031)
  • 4.2 North America Chick Embryo Cell Rabies Vaccine Consumption Value (2020-2031)
  • 4.3 Europe Chick Embryo Cell Rabies Vaccine Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Chick Embryo Cell Rabies Vaccine Consumption Value (2020-2031)
  • 4.5 South America Chick Embryo Cell Rabies Vaccine Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Chick Embryo Cell Rabies Vaccine Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Chick Embryo Cell Rabies Vaccine Sales Quantity by Type (2020-2031)
  • 5.2 Global Chick Embryo Cell Rabies Vaccine Consumption Value by Type (2020-2031)
  • 5.3 Global Chick Embryo Cell Rabies Vaccine Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Chick Embryo Cell Rabies Vaccine Sales Quantity by Application (2020-2031)
  • 6.2 Global Chick Embryo Cell Rabies Vaccine Consumption Value by Application (2020-2031)
  • 6.3 Global Chick Embryo Cell Rabies Vaccine Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Chick Embryo Cell Rabies Vaccine Sales Quantity by Type (2020-2031)
  • 7.2 North America Chick Embryo Cell Rabies Vaccine Sales Quantity by Application (2020-2031)
  • 7.3 North America Chick Embryo Cell Rabies Vaccine Market Size by Country
    • 7.3.1 North America Chick Embryo Cell Rabies Vaccine Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Chick Embryo Cell Rabies Vaccine Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Chick Embryo Cell Rabies Vaccine Sales Quantity by Type (2020-2031)
  • 8.2 Europe Chick Embryo Cell Rabies Vaccine Sales Quantity by Application (2020-2031)
  • 8.3 Europe Chick Embryo Cell Rabies Vaccine Market Size by Country
    • 8.3.1 Europe Chick Embryo Cell Rabies Vaccine Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Chick Embryo Cell Rabies Vaccine Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Chick Embryo Cell Rabies Vaccine Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Chick Embryo Cell Rabies Vaccine Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Chick Embryo Cell Rabies Vaccine Market Size by Region
    • 9.3.1 Asia-Pacific Chick Embryo Cell Rabies Vaccine Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Chick Embryo Cell Rabies Vaccine Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Chick Embryo Cell Rabies Vaccine Sales Quantity by Type (2020-2031)
  • 10.2 South America Chick Embryo Cell Rabies Vaccine Sales Quantity by Application (2020-2031)
  • 10.3 South America Chick Embryo Cell Rabies Vaccine Market Size by Country
    • 10.3.1 South America Chick Embryo Cell Rabies Vaccine Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Chick Embryo Cell Rabies Vaccine Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Chick Embryo Cell Rabies Vaccine Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Chick Embryo Cell Rabies Vaccine Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Chick Embryo Cell Rabies Vaccine Market Size by Country
    • 11.3.1 Middle East & Africa Chick Embryo Cell Rabies Vaccine Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Chick Embryo Cell Rabies Vaccine Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Chick Embryo Cell Rabies Vaccine Market Drivers
  • 12.2 Chick Embryo Cell Rabies Vaccine Market Restraints
  • 12.3 Chick Embryo Cell Rabies Vaccine Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Chick Embryo Cell Rabies Vaccine and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Chick Embryo Cell Rabies Vaccine
  • 13.3 Chick Embryo Cell Rabies Vaccine Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Chick Embryo Cell Rabies Vaccine Typical Distributors
  • 14.3 Chick Embryo Cell Rabies Vaccine Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Chick Embryo Cell Rabies Vaccine market size was valued at US$ 927 million in 2024 and is forecast to a readjusted size of USD 1375 million by 2031 with a CAGR of 5.9% during review period.
    In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
    Chick Embryo Cell Rabies Vaccine (often referred to as CCEV) is a type of rabies vaccine that is produced using chick embryo cells as the medium for growing the rabies virus. The virus is then inactivated (killed) to create a vaccine that can safely stimulate the immune system to protect against rabies infection.
    This report is a detailed and comprehensive analysis for global Chick Embryo Cell Rabies Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Chick Embryo Cell Rabies Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Chick Embryo Cell Rabies Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Chick Embryo Cell Rabies Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Chick Embryo Cell Rabies Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Chick Embryo Cell Rabies Vaccine
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Chick Embryo Cell Rabies Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GlaxoSmithKline, Baxter International, Merck & Co., Inc., Haffkine Bio-Pharmaceutical Corporation, Sanofi Pasteur, Biological E. Limited, Indian Immunologicals Ltd., Vaccine Research Center, Kaketsuken Co., Ltd., Serum Institute of India, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Chick Embryo Cell Rabies Vaccine market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Post-Exposure Prophylaxis Vaccine
    Pre-Exposure Prophylaxis Vaccine
    Market segment by Application
    Clinic
    Hospital
    Pharmacy
    Others
    Major players covered
    GlaxoSmithKline
    Baxter International
    Merck & Co., Inc.
    Haffkine Bio-Pharmaceutical Corporation
    Sanofi Pasteur
    Biological E. Limited
    Indian Immunologicals Ltd.
    Vaccine Research Center
    Kaketsuken Co., Ltd.
    Serum Institute of India
    RxList
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Chick Embryo Cell Rabies Vaccine product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Chick Embryo Cell Rabies Vaccine, with price, sales quantity, revenue, and global market share of Chick Embryo Cell Rabies Vaccine from 2020 to 2025.
    Chapter 3, the Chick Embryo Cell Rabies Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Chick Embryo Cell Rabies Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Chick Embryo Cell Rabies Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Chick Embryo Cell Rabies Vaccine.
    Chapter 14 and 15, to describe Chick Embryo Cell Rabies Vaccine sales channel, distributors, customers, research findings and conclusion.

    Buy now